US01438T1060
US01438T1060
Aldeyra Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 35.265.206 | 60.117.032 | 41.3% | |
| Operating Income | -35.265.206 | -60.117.032 | 41.3% |
| Pretax Income | -33.846.661 | -55.851.444 | 39.4% |
| Net Income Common Stockholders | -33.846.661 | -55.851.444 | 39.4% |
| -- | -- | -- | |
| -- | -- | -- |